Cassava Sciences reported $1.17M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Abbott USD 77M 6M Sep/2025
Biogen USD 31.6M 700K Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Geron USD 4.26M 392K Sep/2025
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Novavax USD 303K 27K Dec/2021
Pfizer USD 0.62 156M Sep/2025